United Community Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.3K Sell
200
-30
-13% -$4.5K 0.01% 358
2026
Q1
$35.1K Sell
230
-1,066
-82% -$163K 0.01% 371
2025
Q4
$179K Hold
1,296
0.07% 174
2025
Q3
$166K Sell
1,296
-50
-4% -$6.1K 0.05% 221
2025
Q2
$163K Sell
1,346
-95
-7% -$10.7K 0.06% 203
2025
Q1
$161K Hold
1,441
0.06% 204
2024
Q4
$140K Hold
1,441
0.05% 211
2024
Q3
$166K Sell
1,441
-295
-17% -$33.5K 0.06% 201
2024
Q2
$185K Sell
1,736
-1,366
-44% -$137K 0.07% 192
2024
Q1
$306K Buy
3,102
+1,351
+77% +$139K 0.12% 137
2023
Q4
$177K Buy
1,751
+10
+0.6% +$965 0.07% 195
2023
Q3
$177K Buy
1,741
+1,246
+252% +$126K 0.09% 162
2023
Q2
$50K Buy
495
+300
+154% +$30K 0.04% 178
2023
Q1
$17.9K Hold
195
0.02% 194
2022
Q4
$17.7K Hold
195
0.02% 209
2022
Q3
$14.8K Hold
195
0.02% 214
2022
Q2
$16.5K Buy
195
+30
+18% +$2.63K 0.02% 213
2022
Q1
$14.5K Buy
+165
New +$14.3K 0.01% 220

Other funds holding NVS

United Community Bank's NVS Position: Q2 2026 in Review

United Community Bank reduced its Novartis (NVS) stake by 13% in Q2 2026, selling an estimated $4.5K and leaving 200 shares worth $31.3K. The position accounts for 0.01% of the portfolio, ranked #358.

United Community Bank first reported a position in NVS in Q1 2022 and has held it in 18 quarters since. The position peaked at $306K in Q1 2024. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • United Community Bank held 200 shares of Novartis worth $31.3K as of Q2 2026.
  • United Community Bank sold 30 Novartis shares in Q2 2026, an estimated $4.5K.
  • Novartis made up 0.01% of United Community Bank's portfolio in Q2 2026, its #358 holding.
  • United Community Bank first reported a position in Novartis in Q1 2022 and has held it in 18 quarters since.
  • United Community Bank's Novartis position peaked at $306K in Q1 2024.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on United Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.